267 related articles for article (PubMed ID: 16194404)
1. [The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis].
Liu B; Guo CY; Liu WQ; Wu N; Xing Q
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):566-9. PubMed ID: 16194404
[TBL] [Abstract][Full Text] [Related]
2. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
[TBL] [Abstract][Full Text] [Related]
4. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
[TBL] [Abstract][Full Text] [Related]
5. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
6. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
7. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis.
Yildirim K; Erdal A; Karatay S; Melikoğlu MA; Uğur M; Senel K
South Med J; 2004 Apr; 97(4):350-3. PubMed ID: 15108827
[TBL] [Abstract][Full Text] [Related]
8. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
[TBL] [Abstract][Full Text] [Related]
9. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
[TBL] [Abstract][Full Text] [Related]
10. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
Kilic G; Kilic E; Ozgocmen S
Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
[TBL] [Abstract][Full Text] [Related]
11. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis.
van Denderen JC; van der Horst-Bruinsma I; Bezemer PD; Dijkmans BA
J Rheumatol; 2003 Jul; 30(7):1558-60. PubMed ID: 12858458
[TBL] [Abstract][Full Text] [Related]
13. The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty.
Ghanem E; Antoci V; Pulido L; Joshi A; Hozack W; Parvizi J
Int J Infect Dis; 2009 Nov; 13(6):e444-9. PubMed ID: 19473865
[TBL] [Abstract][Full Text] [Related]
14. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
[TBL] [Abstract][Full Text] [Related]
15. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review.
Ruof J; Stucki G
J Rheumatol; 1999 Apr; 26(4):966-70. PubMed ID: 10229429
[TBL] [Abstract][Full Text] [Related]
16. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.
Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM
Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863
[TBL] [Abstract][Full Text] [Related]
17. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
DU XN; Li Y; Zhang SL; Zhu J; Huang F
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
[TBL] [Abstract][Full Text] [Related]
18. Serum procalcitonin levels in patients with ankylosing spondylitis.
Ozmen M; Oktay E; Tarhan EF; Aslan O; Oflazoglu U; Koseoglu MH
Int J Rheum Dis; 2016 May; 19(5):500-5. PubMed ID: 24798190
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 3A in Ankylosing Spondylitis.
Liao HT; Lin YF; Chou CT; Tsai CY
J Microbiol Immunol Infect; 2019 Feb; 52(1):151-157. PubMed ID: 28736223
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome.
Nashel DJ; Petrone DL; Ulmer CC; Sliwinski AJ
J Rheumatol; 1986 Apr; 13(2):364-7. PubMed ID: 3723498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
